These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 20920560)
1. Comparison of in vitro cell models in predicting in vivo brain entry of drugs. Hakkarainen JJ; Jalkanen AJ; Kääriäinen TM; Keski-Rahkonen P; Venäläinen T; Hokkanen J; Mönkkönen J; Suhonen M; Forsberg MM Int J Pharm; 2010 Dec; 402(1-2):27-36. PubMed ID: 20920560 [TBL] [Abstract][Full Text] [Related]
2. Similar molecular descriptors determine the in vitro drug permeability in endothelial and epithelial cells. Hakkarainen JJ; Pajander J; Laitinen R; Suhonen M; Forsberg MM Int J Pharm; 2012 Oct; 436(1-2):426-43. PubMed ID: 22750947 [TBL] [Abstract][Full Text] [Related]
3. In vitro models for the blood-brain barrier. Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540 [TBL] [Abstract][Full Text] [Related]
4. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709 [TBL] [Abstract][Full Text] [Related]
5. How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability? Avdeef A Eur J Pharm Sci; 2011 Jun; 43(3):109-24. PubMed ID: 21514381 [TBL] [Abstract][Full Text] [Related]
6. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068 [TBL] [Abstract][Full Text] [Related]
7. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Bachmeier CJ; Trickler WJ; Miller DW Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372 [TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. Pardridge WM; Triguero D; Yang J; Cancilla PA J Pharmacol Exp Ther; 1990 May; 253(2):884-91. PubMed ID: 2338660 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison. Carrara S; Reali V; Misiano P; Dondio G; Bigogno C Int J Pharm; 2007 Dec; 345(1-2):125-33. PubMed ID: 17624703 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability. Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834 [TBL] [Abstract][Full Text] [Related]
11. Validation of cell culture models for the intestine and the blood-brain barrier and comparison of drug permeation. Bock U; Flötotto T; Haltner E ALTEX; 2004; 21 Suppl 3():57-64. PubMed ID: 15057409 [TBL] [Abstract][Full Text] [Related]
12. Methods to assess drug permeability across the blood-brain barrier. Nicolazzo JA; Charman SA; Charman WN J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894 [TBL] [Abstract][Full Text] [Related]
13. Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. van Bree JB; de Boer AG; Danhof M; Ginsel LA; Breimer DD J Pharmacol Exp Ther; 1988 Dec; 247(3):1233-9. PubMed ID: 3204515 [TBL] [Abstract][Full Text] [Related]
14. The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity. Fagerholm U Drug Discov Today; 2007 Dec; 12(23-24):1076-82. PubMed ID: 18061888 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. Wang Q; Rager JD; Weinstein K; Kardos PS; Dobson GL; Li J; Hidalgo IJ Int J Pharm; 2005 Jan; 288(2):349-59. PubMed ID: 15620875 [TBL] [Abstract][Full Text] [Related]
16. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery. Lacombe O; Videau O; Chevillon D; Guyot AC; Contreras C; Blondel S; Nicolas L; Ghettas A; Bénech H; Thevenot E; Pruvost A; Bolze S; Krzaczkowski L; Prévost C; Mabondzo A Mol Pharm; 2011 Jun; 8(3):651-63. PubMed ID: 21438632 [TBL] [Abstract][Full Text] [Related]
17. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs. Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639 [TBL] [Abstract][Full Text] [Related]
18. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain. Sun H; Bungay PM; Elmquist WF J Pharmacol Exp Ther; 2001 Jun; 297(3):991-1000. PubMed ID: 11356921 [TBL] [Abstract][Full Text] [Related]
19. Central nervous system distribution kinetics of indinavir in rats. Hamidi M J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849 [TBL] [Abstract][Full Text] [Related]
20. Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay. Thiel-Demby VE; Humphreys JE; St John Williams LA; Ellens HM; Shah N; Ayrton AD; Polli JW Mol Pharm; 2009; 6(1):11-8. PubMed ID: 19248229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]